See how well iFuse TORQ TNT works for pelvic fragility fractures
Official title: Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Run by SI-BONE, Inc. · NCT07530497 · Data updated 2026-11-12
This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | SI-BONE, Inc. Industry-sponsored |
| Locations | 3 sites (Edina, Minnesota and 2 other locations) |
| Status | Recruiting |
| Started | August 24, 2026 |
| Main results expected | February 2028 |
| Study ends | August 2028 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07530497 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Candidates are adults 60 years or older with pelvic fragility fractures who are planned to receive at least one iFuse TORQ TNT implant.
✕Probably not a fit
Patients without fragility pelvic fractures or those not undergoing iFuse TORQ TNT placement may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
REBAR is a prospective, multicenter, single-arm study that observes patients treated with the iFuse TORQ TNT device in routine clinical practice. It focuses on outcomes after pelvic fixation for fragility-related pelvic fractures. The trial collects real-world data on safety, pain, mobility, and function without randomization or a control group. Participants are adults 60 years and older who require pelvic fixation with the device. The study aims to describe how the device performs outside of a controlled trial setting.
Why it matters
Potential benefit: If successful, this study could demonstrate real-world effectiveness and safety of the device for fragility-related pelvic fractures.
How similar studies have gone: Other observational assessments of this device in real-world settings have reported favorable outcomes in similar pelvic fracture populations, though randomized data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥ 60 years of age at screening 2. Pelvic pain correlating with fracture location that began EITHER within 6 weeks of a known low-energy traumatic event, OR pelvic insufficiency fracture with pain that is limiting mobility 3. Diagnostic imaging (X-ray and CT) showing fracture of the pelvis that correlates with pain location 4. Patient is scheduled for pelvic fixation using at least one iFuse TORQ TNT 5. Patient and/or patient's legally authorized representative (LAR) understands and is willing and able to provide written informed consent 6. Patient agrees to comply with study schedule of assessments 7. Patient and/or patient's proxy can complete study-related surveys 8. Patient was able to ambulate prior to index fracture Exclusion Criteria: 1. Any known anatomic issues that could prevent placement of iFuse TORQ TNT 2. Implants already in the pelvis (e.g. lumbopelvic fixation) that could interfere with placement of the study device(s) 3. Patient requires lumbosacral pelvic fixation as part of index procedure 4. Prominent neurologic or uncontrolled psychiatric condition that would interfere with study participation or regaining of physical function related to pelvic fracture and is unable to provide a health care proxy to complete study assessments. 5. Estimated lifespan \< 12 months 6. Presence of tumor, lytic lesion, infection, or soft tissues that precludes safe internal fixation 7. Not candidate for surgery due to underlying medical illness 8. Social situation that makes 12-month follow-up unlikely 9. History of recent (within 1 year) non-index pelvic fracture with non-union 10. Other clinically active fragility fracture of spine, hip or arms/legs that could impair recovery from sacral fracture 11. Known allergy to titanium or titanium alloys 12. Known or suspected active drug or alcohol abuse, including opioids 13. Patient is a prisoner or ward of the state 14. Patient is already participating in an investigational clinical trial that may interfere with implant placement or study follow-up
Where it's running
-
Twin Cities Orthopedics
Edina, Minnesota, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Orthopaedic Associates of Reading
Wyomissing, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Director of Clinical Affairs
- Email: clinicalaffairs@si-bone.com
- Phone: 408-207-0700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lumbar and sacroiliac fusion with previously implanted devices
This project will collect past and new data to see how well Spinal Simplicity lumbar and sacroiliac fusion implants work for adults who already received them.
-
See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
Stecco Fascial Manipulation vs Muscle Energy Technique for Sacroiliac Joint Pain
This trial tests whether Stecco fascia therapy or Muscle Energy Technique better reduces pain and improves movement in adults with sacroiliac joint dysfunction.
-
Core stability vs hip strengthening for sacroiliac joint dysfunction
A small randomized trial tests whether core stability exercises or hip strengthening exercises better reduce pain and improve function for people with unilateral sacroiliac joint dysfunction.
-
Autogenic vs. Reciprocal Inhibition Techniques for SI Joint Dysfunction
The study tests two muscle-lengthening techniques (autogenic inhibition and reciprocal inhibition) to see if they reduce pain and improve function and walking in adults with sacroiliac joint dysfunction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.